PLCG2 was also found to be an essential regulator of CRC tumor microenvironment as it could inhibit immune-activated cell infiltration (CD8+ T cells) and promote immune-suppressed cell infiltration (Treg cells) and the expression of immune checkpoints, leading to the immune escape of CRC. Here, PLCG2 is linked to neoplasm.